Skip to main content
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.

  • Researcher in a lab

    What Causes Parkinson’s? Four New Projects Look for Contributors in Environment

    Grantees are reviewing records for connections between Parkinson’s and air pollution, pesticides and exposures seen in military service.

  • Dr. Carlie Tanner

    Neurology Today Profiles PPMI Co-Principal Investigator Carlie Tanner: “You couldn’t ask for more from a scientific career.”

    Earlier this month, PPMI co-principal investigator Carlie Tanner, MD, PhD, professor of neurology at the Weill Institute for Neurosciences, University of California, San Francisco, was featured in…

  • Brian Duggan

    PPMI: Our Study to Predict and Prevent Parkinson’s Needs You

    For more than 10 years, thousands of patients, scientists and volunteers have contributed to The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Progression Markers Initiative …

  • Test tubes in a research lab.

    Potential Therapy Targeting Key Parkinson’s Protein Advances in Human Trials

    Partners Prothena and Roche have enrolled the first participant in their Phase IIb trial of an alpha-synuclein antibody.

  • KML_ClinicPhoto.jpg

    Overcoming Motivational Roadblocks to Fitness

    A new project funded by The Michael J. Fox Foundation and the American Occupational Therapy Foundation uses goal setting, feedback and self-management strategies to help people with Parkinson’s…

  • New Study Examines Impulse Control Disorders and Parkinson's Drugs

    News in Context: LRRK2 Therapy Reports Positive Phase I Findings

    Biogen and Denali announced their drug to lower LRRK2 activity was safe and moved markers of protein activity closer to normal with their tests.

Gloved hand holding research samples.

Be Part of the Answer

You have the power to impact your future and the future of millions living with Parkinson's disease. Explore clinical research participation today.

Join a Study
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.